ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
Bayer announced today that data from 13 new analyses from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented at the American College of Cardiology (ACC) 74th ...
Zacks Investment Research on MSN15hOpinion
5 Large Drug Stocks to Watch as Industry Recovers
The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...